Neurobiology Companies and Organizations

CNS therapies

Axsome Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing novel medicines for the management of central nervous system (CNS) disorders. 

Developing therapeutics to address neurological disabilities like Alzheimers disease and Downs Syndrome.

BioArctic is a Swedish research intensive biopharma company aimed at developing new treatments that address the causes of diseases that affect the Central Nervous System. 

Biohaven is a clinical-stage biopharmaceutical company with a portfolio of innovative, late-stage product candidates targeting neurological diseases, including rare disorders. 

BioXcel is a biopharmaceutical company that uses artificial intelligence and big data analytics to develop medicines in immuno-oncology, neuroscience, and rare diseases with high unmet need

Cognitive Genetics LLC (CogGen) is a pre-commercial consumer healthcare company developing the first pre-symptomatic genetic screening panel for predisposition ...

Convelo Therapeutics identifies candidate treatments capable of directly stimulating stem cells in the central nervous system to form new myelin. 

CuraSen Therapeutics is focused on the discovery and development of therapies to treat neurodegenerative diseases, including Parkinson’s Disease, Alzheimer’s Disease and less common ...